Everett E. Vokes
Impact in
- Otorhinolaryngology top 0.01%
- Head and Neck Cancer Studies
- Oncology top 0.02%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
Papers in
- Oncology 353
- Lung Cancer Research Studies 133
- Cancer Immunotherapy and Biomarkers 55
- Cancer Diagnosis and Treatment 45
-
- Lung Cancer Treatments and Mutations 213
- Lung Cancer Diagnosis and Treatment 113
- Co-authors
- Ralph R. Weichselbaum (83 shared papers)Daniel J. Haraf (160 shared papers)Waun Ki Hong (7 shared papers)Ezra E.W. Cohen (111 shared papers)Scott M. Lippman (6 shared papers)Joseph K. Salama (47 shared papers)Kerstin Stenson (79 shared papers)Tanguy Y. Seiwert (96 shared papers)
- Journals
- Journal of Clinical Oncology (263 papers)Journal of Thoracic Oncology (54 papers)International Journal of Radiation Oncology*Biology*Physics (46 papers)Annals of Oncology (46 papers)Lung Cancer (44 papers)
- Partner nations
- United StatesFranceCanada
In The Last Decade
Everett E. Vokes
764 papers receiving 37.1k citations
Everett E. Vokes's Hit Papers
Peers
Comparison fields: 5 of 174
- Otorhinolaryngology 8.8k
- Oncology 14.5k
- Pulmonary and Respiratory Medicine 11.5k
- Cancer Research 2.6k
- Speech and Hearing 758
Countries citing papers authored by Everett E. Vokes
This map shows the geographic impact of Everett E. Vokes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Everett E. Vokes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Everett E. Vokes more than expected).
Fields of papers citing papers by Everett E. Vokes
This network shows the impact of papers produced by Everett E. Vokes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Everett E. Vokes. The network helps show where Everett E. Vokes may publish in the future.
Co-authors
The 25 scholars most cited alongside Everett E. Vokes, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 792 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Head and Neck Cancer Hit paper breakdown → | 1993 | 1884 |
| 2 | Randomized Phase III Trial of Docetaxel Versus Vinorelbine or Ifosfamide in Patients With Advanced Non–Small-Cell Lung Cancer Previously Treated With Platinum-Containing Chemotherapy Regimens Hit paper breakdown → | 2000 | 1152 |
| 3 | Genetic Variants in the UDP-glucuronosyltransferase 1A1 Gene Predict the Risk of Severe Neutropenia of Irinotecan Hit paper breakdown → | 2004 | 759 |
| 4 | Adjuvant Paclitaxel Plus Carboplatin Compared With Observation in Stage IB Non–Small-Cell Lung Cancer: CALGB 9633 With the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups Hit paper breakdown → | 2008 | 714 |
| 5 | Multicenter Phase II Study of Erlotinib, an Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck Hit paper breakdown → | 2003 | 681 |
| 6 | UGT1A1*28 polymorphism as a determinant of irinotecan disposition and toxicity Hit paper breakdown → | 2002 | 564 |
| 7 | Lung cancer Hit paper breakdown → | 2000 | 539 |
| 8 | Axitinib Is an Active Treatment for All Histologic Subtypes of Advanced Thyroid Cancer: Results From a Phase II Study Hit paper breakdown → | 2008 | 523 |
| 9 | Phase II Trial of ZD1839 in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Hit paper breakdown → | 2003 | 518 |
| 10 | The performance status scale for head and neck cancer patients and the functional assessment of cancer therapy-head and neck scale: A study of utility and validity Hit paper breakdown → | 1996 | 480 |
| 11 | 2004 | 461 | |
| 12 | Metabolic fate of irinotecan in humans: correlation of glucuronidation with diarrhea. | 1994 | 439 |
| 13 | 1996 | 414 | |
| 14 | 2001 | 398 | |
| 15 | 2005 | 376 | |
| 16 | 2007 | 365 | |
| 17 | 2009 | 358 | |
| 18 | 2007 | 349 | |
| 19 | 1990 | 313 | |
| 20 | 2005 | 312 |
About Everett E. Vokes
Everett E. Vokes is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Otorhinolaryngology, Surgery and Molecular Biology, having authored 792 papers that have together received 38.3k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (239 papers), Lung Cancer Treatments and Mutations (213 papers), Lung Cancer Research Studies (133 papers), Lung Cancer Diagnosis and Treatment (113 papers), Cancer Immunotherapy and Biomarkers (55 papers), Cancer Diagnosis and Treatment (45 papers), Cancer Genomics and Diagnostics (41 papers) and Head and Neck Surgical Oncology (36 papers). The work is most often cited by research in Otorhinolaryngology (8.8k citations), Oncology (14.5k citations), Pulmonary and Respiratory Medicine (11.5k citations), Cancer Research (2.6k citations) and Speech and Hearing (758 citations). Everett E. Vokes has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Ralph R. Weichselbaum, Daniel J. Haraf, Waun Ki Hong, Ezra E.W. Cohen, Scott M. Lippman, Joseph K. Salama, Kerstin Stenson, Tanguy Y. Seiwert, Ann M. Mauer and Walter M. Stadler. Their work appears in journals such as Journal of Clinical Oncology, Journal of Thoracic Oncology, International Journal of Radiation Oncology*Biology*Physics, Annals of Oncology and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.